FDA Inspection 1060515 — Smith & Nephew Wound Management
The FDA completed an inspection of Smith & Nephew Wound Management on June 29, 2018 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 29, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fort Worth, TX (United States)